-
CGON Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
CG Oncology, Inc. Common stock (CGON)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 43.41 mm | 43.41 mm | 43.41 mm | 43.41 mm | 43.41 mm | 43.41 mm |
Cash burn (monthly) | (no burn) | 2.84 mm | 9.43 mm | 6.38 mm | 20.00 k | 2.18 mm |
Cash used (since last report) | n/a | 14.42 mm | 47.93 mm | 32.44 mm | 101.63 k | 11.06 mm |
Cash remaining | n/a | 28.99 mm | -4.51 mm | 10.97 mm | 43.31 mm | 32.35 mm |
Runway (months of cash) | n/a | 10.2 | -0.5 | 1.7 | 2165.5 | 14.9 |
13F holders | Current |
---|---|
Total holders | 146 |
Opened positions | 37 |
Closed positions | 18 |
Increased positions | 60 |
Reduced positions | 28 |
13F shares | Current |
---|---|
Total value | 1.86 tn |
Total shares | 87.48 mm |
Total puts | 34.50 k |
Total calls | 198.70 k |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
Decheng Capital | 6.37 mm | $182.74 bn |
Vanguard | 5.86 mm | $168.10 bn |
Decheng Capital Global Life Sciences Fund IV | 5.32 mm | $160.28 mm |
BlackRock | 4.06 mm | $116.47 bn |
TCG Crossover Management | 3.67 mm | $105.26 bn |
Unique Diamond Investments | 3.59 mm | $108.27 mm |
TCG Crossover GP I | 3.57 mm | $158.52 mm |
Kissei Pharmaceutical | 3.54 mm | $131.11 mm |
Braidwell | 3.28 mm | $94.17 bn |
Longitude Capital Partners IV | 3.19 mm | $118.05 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Feb 25 | Leonard E Post | Common Stock | Sell | Dispose S | No | Yes | 28.61 | 1,000 | 28.61 k | 0 |
18 Feb 25 | Leonard E Post | Common Stock | Option exercise | Acquire M | No | No | 0.6 | 1,000 | 600.00 | 1,000 |
18 Feb 25 | Leonard E Post | Director Stock Option Common Stock | Option exercise | Dispose M | No | No | 0.6 | 1,000 | 600.00 | 131,077 |
13 Jan 25 | Leonard E Post | Common Stock | Sell | Dispose S | No | Yes | 29.66 | 1,000 | 29.66 k | 0 |
13 Jan 25 | Leonard E Post | Common Stock | Option exercise | Acquire M | No | No | 0.6 | 1,000 | 600.00 | 1,000 |
13 Jan 25 | Leonard E Post | Director Stock Option Common Stock | Option exercise | Dispose M | No | No | 0.6 | 1,000 | 600.00 | 132,077 |
16 Dec 24 | Leonard E Post | Common Stock | Sell | Dispose S | No | Yes | 28.84 | 1,000 | 28.84 k | 0 |
16 Dec 24 | Leonard E Post | Common Stock | Option exercise | Acquire M | No | No | 0.6 | 1,000 | 600.00 | 1,000 |
16 Dec 24 | Leonard E Post | Stock Option Common Stock | Option exercise | Dispose M | No | No | 0.6 | 1,000 | 600.00 | 133,077 |
16 Dec 24 | Hong Fang Song | Common Stock | Sell | Dispose S | Yes | No | 28 | 700,000 | 19.60 mm | 3,003,931 |